Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Peter K Kaiser
Safety and Efficacy of Ranibizumab and Bevacizumab for the Treatment of Neovascular Age-Related Macular Degeneration
European Ophthalmic Review
Related publications
Ranibizumab Versus Verteporfin for Neovascular Age-Related Macular Degeneration
New England Journal of Medicine
Medicine
Cost-Effectiveness of Bevacizumab and Ranibizumab for Newly Diagnosed Neovascular Macular Degeneration
Ophthalmology
Ophthalmology
Patterns of Early and Delayed Visual Response to Ranibizumab Treatment for Neovascular Age-Related Macular Degeneration
JAMA Ophthalmology
Ophthalmology
Baseline Predictors for One-Year Visual Outcomes With Ranibizumab or Bevacizumab for Neovascular Age-Related Macular Degeneration
Ophthalmology
Ophthalmology
Effect of ARMS2 Gene Polymorphism on Intravitreal Ranibizumab Treatment for Neovascular Age-Related Macular Degeneration
Genetics and Molecular Research
Medicine
Genetics
Molecular Biology
Treatment of Age-Related Neovascular Macular Degeneration: The Patient’s Perspective
Graefe's Archive for Clinical and Experimental Ophthalmology
Molecular Neuroscience
Ophthalmology
Sensory Systems
Cellular
Ranibizumab Monotherapy in Neovascular Age-Related Macular Degeneration With Pigment Epithelial Detachment
Journal of Clinical & Experimental Ophthalmology
Development and Testing of a Patient-Derived Questionnaire for Treatment of Neovascular Age-Related Macular Degeneration: Dimensions of Importance in Treatment of Neovascular Age-Related Macular Degeneration
Acta Ophthalmologica
Medicine
Ophthalmology
Ranibizumab in Neovascular Age-Related Macular Degeneration: A 5-Year Follow-Up
Clinical Ophthalmology
Ophthalmology
